Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 7 (6), 435-40

Update on Augmentation of Antidepressant Response in Resistant Depression


Update on Augmentation of Antidepressant Response in Resistant Depression

Charles DeBattista et al. Curr Psychiatry Rep.


Most patients in acute depression trials fail to achieve remission with antidepressant monotherapy. Many patients seem to require more than one medication to achieve remission or adequate response. Augmentation strategies are commonly used in clinical practice, but most have been poorly studied. In addition, better-studied strategies, such as the use of lithium and thyroid augmentation, have not been well investigated in combination with newer antidepressants. Various novel strategies are being investigated as augmenting agents, including selective dopamine agonists, sex steroids, norepinephrine reuptake inhibitors, glucocorticoid-specific agents, and newer anticonvulsants. We review the status of augmentation strategies in the treatment of depression.

Similar articles

See all similar articles

Cited by 3 PubMed Central articles

  • The Impact of Residual Symptoms in Major Depression
    JA Israel. Pharmaceuticals (Basel) 3 (8), 2426-2440. PMID 27713362. - Review
    The current definition of remission from major depressive disorder does not fully take into account all aspects of patient recovery. Residual symptoms of depression are v …
  • Antipsychotics Possessing Antidepressive Efficacy Increase Golf Protein in Rat Striatum
    H Taoka et al. Psychopharmacology (Berl) 201 (2), 229-35. PMID 18777019.
    We postulate that the increase in Golf protein levels result in an increase the proportion of D1 receptors in the high-affinity state and that augmentation of the dopamin …
  • Treatments in Depression
    F Duval et al. Dialogues Clin Neurosci 8 (2), 191-206. PMID 16889105. - Review
    Major depression is believed to be a multifactorial disorder involving predisposing temperament and personality traits, exposure to traumatic and stressful life events, a …


    1. Arch Gen Psychiatry. 2005 Feb;62(2):154-62 - PubMed
    1. Am J Psychiatry. 2001 Dec;158(12 ):2080-2 - PubMed
    1. Biol Psychiatry. 2004 Feb 1;55(3):296-300 - PubMed
    1. J Clin Psychiatry. 2003;64 Suppl 1:19-23 - PubMed
    1. Int Clin Psychopharmacol. 2005 Jan;20(1):9-11 - PubMed